Tyro Capital Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-177,107
| Closed | -$3.03M | – | 14 |
|
|
2025
Q1 | $3.03M | Buy |
177,107
+25,651
| +17% | +$438K | 1.13% | 12 |
|
|
2024
Q4 | $3.75M | Sell |
151,456
-100,693
| -40% | -$2.49M | 1.23% | 11 |
|
|
2024
Q3 | $7.19M | Buy |
252,149
+1,529
| +0.6% | +$43.6K | 2.32% | 12 |
|
|
2024
Q2 | $6.62M | Buy |
250,620
+152,953
| +157% | +$4.04M | 3% | 14 |
|
|
2024
Q1 | $3.16M | Buy |
97,667
+52,667
| +117% | +$1.7M | 1.82% | 14 |
|
|
2023
Q4 | $1.9M | Buy |
+45,000
| New | +$1.9M | 1.34% | 13 |
|